CIK 0001160308 · Non-accelerated filer<br>Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841318182
- Phone
- 51285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −12,500 | 15,000 | ||
| 2026-06-22 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −87,650 | 187,500 | ||
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise | +80,684 | $1.51 | $122K | 366,729 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −24,174 | $5.04 | $122K | 342,555 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise | +75,000 | $1.59 | $119K | 417,555 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −23,661 | $5.04 | $119K | 393,894 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise | +130,650 | $1.23 | $161K | 524,544 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −31,885 | $5.04 | $161K | 492,659 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise | +43,063 | $1.11 | $48K | 535,722 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −9,485 | $5.04 | $48K | 526,237 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise | +12,500 | $4.45 | $56K | 538,737 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −11,037 | $5.04 | $56K | 527,700 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise | +24,850 | $3.35 | $83K | 552,550 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Shares withheld for taxes | −16,518 | $5.04 | $83K | 536,032 |
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −80,684 | 0 | ||
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −75,000 | 75,000 | ||
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −130,650 | 129,350 | ||
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −43,063 | 56,937 | ||
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −12,500 | 27,500 | ||
| 2026-03-18 | Lowrance David L Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −24,850 | 275,150 |
Page 2 of 11 · 202 trades